US 11813257
Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors
granted A61KA61K31/4178A61K31/496
Quick answer
US patent 11813257 (Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors) held by Disc Medicine, Inc. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Disc Medicine, Inc.
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/4178, A61K31/496, A61K31/69, A61K31/785